Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EU Explains Plans For Use Of ‘Last Resort’ Compulsory Licensing

Executive Summary

The first stage of the EU’s proposal to revamp the compulsory licensing system and prepare the bloc for future health crises is almost complete. The next steps are to publish an impact assessment, run a public consultation, and produce a draft regulation by the first quarter of 2023.

You may also be interested in...

Industry Skeptical Of EU Moves To Facilitate Compulsory Licensing

Industry representatives in the EU are more welcoming of moves to harmonize supplementary protection certificates, which they say will bring more certainty for stakeholders.

EU Reveals Plans For Unitary SPC & Review Of Compulsory Licensing

The EU has announced two separate legal initiatives, one that would improve IP protections, and another that could weaken them in the event of a future health crisis.

New Zealand Hikes Fees To Reflect Changes In Drug Applications

Following a consultation last year, Medsafe has set new fee levels that take account of both cost-recovery principles and a 4.2% increase in the consumer price index. 





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts